Drug profile · INN
fluticasone propionate
AXOTIDE
fluticasone propionate (AXOTIDE) is a glucocorticoid receptor agonist. Associated with GlaxoSmithKline. Route of administration: topical. Current US regulatory status: approved.
Drug details — fluticasone propionate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 2
- Programs
- 19
- Data quality
- 0.89
Quick answer
fluticasone propionate (AXOTIDE) is a glucocorticoid receptor agonist. Associated with GlaxoSmithKline. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is fluticasone propionate?
fluticasone propionate (AXOTIDE) is a glucocorticoid receptor agonist. Associated with GlaxoSmithKline. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for fluticasone propionate?
AXOTIDE is a marketed brand name for fluticasone propionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluticasone propionate?
fluticasone propionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.